Medication info
Rabeprazole Sodium Tablet 20 mg

Rabeprazole Sodium Tablet 20 mg

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
White Life Science Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging x 2)
Approval status
Active

MFDS item code 201404296 · Approved 2014.09.22 · Insurance code 625200830

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is needed. After symptoms have resolved, subsequent symptoms may be controlled with on-demand treatment using 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution because hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
White Life Science Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • Helicobacter pylori infection gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers, helping to improve erosive or ulcerative gastroesophageal reflux disease. It also alleviates symptoms of gastroesophageal reflux disease and is effective for long-term maintenance therapy. For patients with gastrointestinal ulcers infected with Helicobacter pylori, it enhances the treatment effect when used in combination with antibiotics, and it is also applicable in the treatment of Zollinger-Ellison syndrome. It is widely used to improve various diseases of the stomach and esophagus.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcer and up to 6 weeks for duodenal ulcer. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is needed. After symptoms have resolved, subsequent symptoms may be controlled with on-demand treatment using 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year. ○ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ○ Elderly patients Administer with caution because hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used in patients with specific allergic reactions or when combined with certain antibiotics, as side effects may occur. It is also safest for pregnant or nursing women to avoid taking this medication. Patients with impaired liver function or the elderly should use this medication cautiously and pay special attention if there is a history of allergies. This medication can cause hypersensitivity reactions such as skin rash or itching, so if these symptoms appear, it must be discontinued immediately. Regular blood tests, liver function tests, etc., are important to detect abnormal signs early. Side effects may occur in various parts of the body, including the heart, gastrointestinal tract, nervous system, respiratory system, and skin, so one should observe their health carefully. Long-term use may increase the risk of fractures and cause electrolyte imbalances such as hypomagnesemia, necessitating regular testing. This medication strongly suppresses gastric acid secretion and may slightly increase the risk of bacterial infections in the gastrointestinal tract. Caution is advised when driving or operating machinery, as drowsiness or dizziness may occur. There may be drug interactions, especially when taken with warfarin, methotrexate, or antibiotics, so consultation with a healthcare provider is necessary. This medication should be swallowed whole and not chewed or crushed, and must be kept out of the reach of children. It is important to consult a physician or pharmacist immediately if any unusual symptoms or discomfort occur during use.

Side effects

Rash, urticaria, pruritus, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, electrocardiogram abnormalities, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QT prolongation, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, blood in stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, fatty liver, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, paresthesia, tremors, weakness, hyperesthesia, drowsiness, lightheadedness, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, hypervolemia, muscle weakness in extremities, sensory impairment, reduced grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, nosebleed, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, diplopia, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated blood thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, malaise, weight gain, visual disturbances, anorexia, neck stiffness, phototoxic reaction, hangover effects, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular dermatitis, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, systemic lupus erythematosus, cutaneous lupus erythematosus, nausea, halitosis, dry mouth, facial swelling, flushing, palpitations, increased intraocular pressure, urinary tract infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.